Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+3.94%
|
$13,580
$194.1 P/Share
|
|
Jan 08
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+3.12%
|
$20,564
$194.1 P/Share
|
|
Jan 08
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.37%
|
$13,580
$194.1 P/Share
|
|
Jan 08
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+50.0%
|
$9,118
$194.1 P/Share
|
|
Jan 04
2021
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
30,187
-40.91%
|
$5,524,221
$183.9 P/Share
|
|
Jan 04
2021
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,187
+41.46%
|
$30,187
$1.61 P/Share
|
|
Dec 23
2020
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
64,921
+41.2%
|
-
|
|
Dec 23
2020
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Direct |
20,717
+10.8%
|
-
|
|
Dec 23
2020
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
85,638
-100.0%
|
-
|
|
Dec 15
2020
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.88%
|
$567,000
$189.02 P/Share
|
|
Dec 11
2020
|
Steven Jandrich VP, Human Resources |
SELL
Bona fide gift
|
Direct |
300
-16.62%
|
-
|
|
Nov 17
2020
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.85%
|
$510,000
$170.51 P/Share
|
|
Nov 05
2020
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Indirect |
80,000
-11.27%
|
$13,120,000
$164.08 P/Share
|
|
Nov 03
2020
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
7,000
-4.83%
|
$1,008,000
$144.65 P/Share
|
|
Oct 20
2020
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.36%
|
$366,000
$122.34 P/Share
|
|
Oct 09
2020
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.68%
|
$130,000
$130.0 P/Share
|
|
Oct 09
2020
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,267
+2.71%
|
$107,471
$13.6 P/Share
|
|
Oct 09
2020
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
158
+4.72%
|
$20,540
$130.0 P/Share
|
|
Oct 09
2020
|
Chau Quang Khuong Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+4.63%
|
$11,830
$130.0 P/Share
|
|
Oct 09
2020
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
105
+6.03%
|
$13,650
$130.0 P/Share
|
|
Oct 09
2020
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.55%
|
$13,650
$130.0 P/Share
|
|
Oct 09
2020
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
88
+50.0%
|
$11,440
$130.0 P/Share
|
|
Oct 08
2020
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
25,000
-2.22%
|
$3,275,000
$131.98 P/Share
|
|
Aug 18
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
43,543
-100.0%
|
$4,702,644
$108.54 P/Share
|
|
Aug 17
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
94,900
-68.55%
|
$10,154,300
$107.49 P/Share
|
|
Aug 14
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
20,257
-12.76%
|
$2,208,013
$109.03 P/Share
|
|
Aug 13
2020
|
Marilyn C Nelson Director |
SELL
Bona fide gift
|
Indirect |
5,500
-3.12%
|
-
|
|
Aug 13
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
29,251
-15.58%
|
$3,188,359
$109.93 P/Share
|
|
Aug 12
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
42,679
-18.52%
|
$4,566,653
$107.45 P/Share
|
|
Aug 11
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
39,877
-14.75%
|
$4,187,085
$105.78 P/Share
|
|
Aug 10
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
47,700
-15.0%
|
$5,008,500
$105.23 P/Share
|
|
Aug 07
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
28,993
-8.36%
|
$3,073,258
$106.18 P/Share
|
|
Mar 17
2020
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
37,384
+50.03%
|
-
|
|
Mar 17
2020
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
27,735
-24.46%
|
-
|
|
Mar 17
2020
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Direct |
9,649
-6.03%
|
-
|
|
Mar 06
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-59.03%
|
$41,500,000
$83.52 P/Share
|
|
Mar 03
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-13.2%
|
$42,000,000
$84.06 P/Share
|
|
Nov 27
2019
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
53,387
-1.27%
|
$3,790,477
$71.47 P/Share
|
|
Nov 26
2019
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
70,613
-2.42%
|
$4,872,297
$69.86 P/Share
|
|
Apr 22
2019
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
238
+0.21%
|
-
|
|
Apr 22
2019
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
238
-2.36%
|
-
|
|
Mar 08
2019
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
290,231
-16.47%
|
$16,543,167
$57.75 P/Share
|
|
Mar 07
2019
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
68,218
-3.73%
|
$3,751,990
$55.01 P/Share
|
|
Dec 11
2018
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
614,772
-25.15%
|
$22,746,564
$37.6 P/Share
|
|
May 07
2018
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Direct |
312,500
+11.34%
|
$5,000,000
$16.0 P/Share
|
|
May 07
2018
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Direct |
2,131,721
+35.24%
|
-
|
|
May 07
2018
|
Medtronic Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
358,690
+14.91%
|
-
|
|
May 07
2018
|
Johnson & Johnson > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
235,251
+31.86%
|
-
|